Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification01:13

Seizures: Classification

1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chloroindazole based estrogen receptor β ligands with favorable pharmacokinetics promote functional remyelination and visual recovery.

Scientific reports·2025
Same author

Demyelination-induced glutamatergic imbalance mediates hippocampal Hyperexcitability.

Neurobiology of disease·2025
Same author

FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions.

Frontiers in neuroscience·2025
Same author

Decreased mitochondrial activity in the demyelinating cerebellum of progressive multiple sclerosis and chronic EAE contributes to Purkinje cell loss.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Cortical layer-specific abnormalities in auditory responses in a mouse model of Fragile X Syndrome.

Neurobiology of disease·2025
Same author

Neuroglia in epilepsy.

Handbook of clinical neurology·2025

Related Experiment Video

Updated: Mar 8, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

5.0K

Chronic demyelination-induced seizures.

Andrew S Lapato1, Jenny I Szu2, Jonathan P C Hasselmann3

  • 1Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA 92521, USA; Center for Glial-Neuronal Interactions, University of California Riverside, Riverside, CA 92521, USA.

Neuroscience
|February 4, 2017
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis patients have higher epilepsy risk. Chronically demyelinated mice show seizures and brain changes, offering a model to study epilepsy mechanisms.

Keywords:
axon damagecuprizoneelectroencephalographyhippocampusmultiple sclerosisparvalbumin

More Related Videos

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

5.8K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.2K

Related Experiment Videos

Last Updated: Mar 8, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

5.0K
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

5.8K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.2K

Area of Science:

  • Neuroscience
  • Neurology
  • Pathophysiology

Background:

  • Multiple sclerosis (MS) patients exhibit a 3-6 times higher incidence of epilepsy compared to the general population.
  • Seizures in MS correlate with disease severity, rapid disability progression, and mortality.
  • Existing research identifies brain abnormalities in MS patients with seizures, but translational studies on epileptogenesis mechanisms are scarce.

Purpose of the Study:

  • To investigate the potential of chronically demyelinated mice as a model for studying epilepsy in multiple sclerosis.
  • To elucidate the pathophysiological changes associated with demyelination that may lead to seizures.

Main Methods:

  • Induction of chronic demyelination in mice using the cuprizone model over 9-12 weeks.
  • Electrophysiological recordings of dorsal hippocampal electroencephalography (EEG).
  • Immunohistochemical (IHC) analysis of the hippocampal CA1 region, focusing on demyelination, interneurons, gliosis, and aquaporin-4 (AQP4) expression.

Main Results:

  • Chronically demyelinated mice displayed significant alterations in hippocampal EEG and overt seizure activity.
  • IHC analysis revealed extensive demyelination, loss of parvalbumin-positive (PV+) interneurons, and pronounced gliosis in the hippocampal CA1 region.
  • Changes in aquaporin-4 (AQP4) expression were observed in the affected hippocampal areas.

Conclusions:

  • Chronically demyelinated mice serve as a relevant model for studying demyelination-induced seizures.
  • The observed changes in the hippocampus, including demyelination and interneuron loss, are implicated in the development of seizures in this MS model.
  • This model provides a platform for future research into the mechanisms of epileptogenesis in multiple sclerosis.